With medical marijuana set for reclassification into Schedule III, Midwest businesses could see major impacts in doing ...

The move will bring enormous tax benefits to medical marijuana producers and may speed research into its effects, experts say.

(THE CONVERSATION) When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has ...

CHICAGO - A major shift in federal marijuana policy could have a big impact on Illinois’ cannabis industry. The Trump ...

Researchers and cannabis dispensary owners shared their excitement for possible changes after the Justice Department reclassified medical marijuana to a lower class.

The federal government reclassified marijuana from Schedule I to Schedule III, impacting Oklahoma's medical marijuana businesses.

By Mariam Sunny and Suzanne McGee April 23 (Reuters) - The Department of Justice is reclassifying FDA-approved and state-licensed marijuana as a less dangerous drug, U.S. Acting Attorney General Todd ...

Vermont’s medical and recreational cannabis markets are closely intertwined, complicating how the reclassification as a lower-risk drug could benefit Vermont businesses.

Acting Attorney General Todd Blanche signed an order under President Trump’s direction on Thursday to reclassify state-licensed medical marijuana as a less-dangerous drug — a major change in U.S.